NICE coronavirus guidelines on gastrointestinal and liver conditions and acute myocardial injuries
NICE has published two new rapid coronavirus guidelines on the care of patients with suspected and confirmed COVID-19. They cover the management of disorders of...
IQVIA collaborates to launch accelerated COVID-19 infection survey
IQVIA has joined forces with the Office for National Statistics (ONS), Oxford University and UK Biocentre to launch an accelerated COVID-19 infection survey. They will...
Government launches coronavirus vaccine taskforce as human clinical trials start
The UK Government has launched a new coronavirus vaccine taskforce to drive forward, expedite and co-ordinate efforts to research and then produce a coronavirus vaccine....
NICE recommends VITRAKVI® for children and adults with TRK fusion driven cancer
Bayer announced that VITRAKVI® (larotrectinib) was recommended by the National Institute for Health and Care Excellence (NICE) for the treatment of advanced neurotrophic tyrosine...
Coronavirus convalescent plasma wanted for clinical trial
The NHS Blood and Transplant Service is asking for people who’ve recovered from coronavirus (COVID-19) to donate blood plasma, as part of a potential clinical...
Novartis sponsors hydroxychloroquine clinical trial in hospitalised COVID-19 patients
Novartis has announced that it is to sponsor a large hydroxychloroquine clinical trial in hospitalised COVID-19 patients. Novartis has reached an agreement with the US...
MHRA fast track nod for UK pharma company’s COVID-19 study
4D pharma has received expedited acceptance from the UK Medicines and Healthcare products Regulatory Agency (MHRA) to commence a Phase II study of MRx-4DP0004...
Roche develops new COVID-19 antibody test
Roche has announced the development and upcoming launch of a new COVID-19 antibody test. Its Elecsys® Anti-SARS-CoV-2 serology test will detect antibodies in people...
Cegedim launches free pharmacist training during COVID-19
Cegedim launches free digital training to help pharmacists deliver ongoing care throughout COVID-19. Cegedim Rx, part of the innovative healthcare technology and services company, Cegedim,...
Celltrion identify 14 antibodies that neutralise COVID-19 virus
Celltrion Group has successfully selected the most potent antibody candidates to neutralise COVID-19 virus, SARS-CoV-2. Through a partnership with the Korea Centers for Disease Control...